KIR2DL1 and amyotrophic lateral sclerosis: There were no differences in total peripheral NK cell levels in subjects with ALS versus control subjects or in CD57+, CD62L+, CD94+, KIR2DL1+, and KIR2DL2+ subpopulations (Table 2 and Supplemental Figure 2).